» Articles » PMID: 9311735

Spectrum of Mutations in the Batten Disease Gene, CLN3

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1997 Aug 1
PMID 9311735
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Batten disease (juvenile-onset neuronal ceroid lipofuscinosis [JNCL]) is an autosomal recessive condition characterized by accumulation of lipopigments (lipofuscin and ceroid) in neurons and other cell types. The Batten disease gene, CLN3, was recently isolated, and four disease-causing mutations were identified, including a 1.02-kb deletion that is present in the majority of patients (The International Batten Disease Consortium 1995). One hundred eighty-eight unrelated patients with JNCL were screened in this study to determine how many disease chromosomes carried the 1.02-kb deletion and how many carried other mutations in CLN3. One hundred thirty-nine patients (74%) were found to have the 1.02-kb deletion on both chromosomes, whereas 49 patients (41 heterozygous for the 1.02-kb deletion) had mutations other than the 1.02-kb deletion. SSCP analysis and direct sequencing were used to screen for new mutations in these individuals. Nineteen novel mutations were found: six missense mutations, five nonsense mutations, three small deletions, three small insertions, one intronic mutation, and one splice-site mutation. This report brings the total number of disease-associated mutations in CLN3 to 23. All patients homozygous for mutations predicted to give rise to truncated proteins were found to have classical JNCL. However, a proportion of the patients (n = 4) who were compound heterozygotes for a missense mutation and the 1.02-kb deletion were found to display an atypical phenotype that was dominated by visual failure rather than by severe neurodegeneration. All missense mutations were found to affect residues conserved between the human protein and homologues in diverse species.

Citing Articles

Insight of autonomic dysfunction in CLN3 disease: a study on episodes resembling paroxysmal sympathetic hyperactivity (PSH).

Baekmann C, Handrup M, Molgaard H, Ejerskov C, Jensen H, Ostergaard J Orphanet J Rare Dis. 2024; 19(1):374.

PMID: 39390491 PMC: 11465670. DOI: 10.1186/s13023-024-03336-1.


CLN3 transcript complexity revealed by long-read RNA sequencing analysis.

Zhang H, Minnis C, Gustavsson E, Ryten M, Mole S BMC Med Genomics. 2024; 17(1):244.

PMID: 39367445 PMC: 11451007. DOI: 10.1186/s12920-024-02017-z.


Limited Added Diagnostic Value of Whole Genome Sequencing in Genetic Testing of Inherited Retinal Diseases in a Swiss Patient Cohort.

Maggi J, Koller S, Feil S, Bachmann-Gagescu R, Gerth-Kahlert C, Berger W Int J Mol Sci. 2024; 25(12).

PMID: 38928247 PMC: 11203445. DOI: 10.3390/ijms25126540.


The parent and family impact of CLN3 disease: an observational survey-based study.

Schulz A, Patel N, Brudvig J, Stehr F, Weimer J, Augustine E Orphanet J Rare Dis. 2024; 19(1):125.

PMID: 38500130 PMC: 10949783. DOI: 10.1186/s13023-024-03119-8.


Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases.

Uribe-Carretero E, Rey V, Fuentes J, Tamargo-Gomez I Biology (Basel). 2024; 13(1).

PMID: 38248465 PMC: 10813815. DOI: 10.3390/biology13010034.


References
1.
Zeman W . Presidential address: Studies in the neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol. 1974; 33(1):1-12. DOI: 10.1097/00005072-197401000-00001. View

2.
Mitchison H, Munroe P, ORawe A, Taschner P, De Vos N, Kremmidiotis G . Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Genomics. 1997; 40(2):346-50. DOI: 10.1006/geno.1996.4576. View

3.
Santavuori P . Neuronal ceroid-lipofuscinoses in childhood. Brain Dev. 1988; 10(2):80-3. DOI: 10.1016/s0387-7604(88)80075-5. View

4.
Wisniewski K, Rapin I . Clinico-pathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities. Am J Med Genet Suppl. 1988; 5:27-46. DOI: 10.1002/ajmg.1320310607. View

5.
Dean M, White M, Amos J, Gerrard B, Stewart C, Khaw K . Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell. 1990; 61(5):863-70. DOI: 10.1016/0092-8674(90)90196-l. View